3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
16
Neoplasms
2
Urogenital Neoplasms
1
Prostatic Neoplasms, Castration-Resistant
1
Neoplasm Metastasis
1
Metastatic Castration-resistant Prostate Cancer (mCRPC)
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Bulbo-Spinal Atrophy, X-Linked
1
Adenocarcinoma
1
Interventions
enzalutamide
2
ostarine
1
exemestane
1
abiraterone
1
Prednisolone
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Bulbo-Spinal Atrophy, X-Linked
×
abiraterone
×
Clear all
NCT06764485
2026-05-06
rechARge
Celgene
Phase 3
Recruiting
960 enrolled